244 related articles for article (PubMed ID: 30745413)
1. The Molecular Chaperone Heat Shock Protein 70 Controls Liver Cancer Initiation and Progression by Regulating Adaptive DNA Damage and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Signaling Pathways.
Cho W; Jin X; Pang J; Wang Y; Mivechi NF; Moskophidis D
Mol Cell Biol; 2019 May; 39(9):. PubMed ID: 30745413
[TBL] [Abstract][Full Text] [Related]
2. Targeted deletion of ER chaperone GRP94 in the liver results in injury, repopulation of GRP94-positive hepatocytes, and spontaneous hepatocellular carcinoma development in aged mice.
Chen WT; Ha D; Kanel G; Lee AS
Neoplasia; 2014 Aug; 16(8):617-26. PubMed ID: 25220589
[TBL] [Abstract][Full Text] [Related]
3. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
[TBL] [Abstract][Full Text] [Related]
4. Extracellular HSP70-peptide complexes promote the proliferation of hepatocellular carcinoma cells via TLR2/4/JNK1/2MAPK pathway.
Zhe Y; Li Y; Liu D; Su DM; Liu JG; Li HY
Tumour Biol; 2016 Oct; 37(10):13951-13959. PubMed ID: 27492456
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice.
Wang Z; Yan J; Lin H; Hua F; Wang X; Liu H; Lv X; Yu J; Mi S; Wang J; Hu ZW
Hepatology; 2013 May; 57(5):1869-81. PubMed ID: 23299825
[TBL] [Abstract][Full Text] [Related]
6. A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish.
Nguyen AT; Emelyanov A; Koh CH; Spitsbergen JM; Lam SH; Mathavan S; Parinov S; Gong Z
Dis Model Mech; 2011 Nov; 4(6):801-13. PubMed ID: 21729876
[TBL] [Abstract][Full Text] [Related]
7. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
[TBL] [Abstract][Full Text] [Related]
8. Tg737 regulates epithelial-mesenchymal transition and cancer stem cell properties via a negative feedback circuit between Snail and HNF4α during liver stem cell malignant transformation.
Huang Q; Pu M; Zhao G; Dai B; Bian Z; Tang H; Chen C; Liu W; Qu X; Shen L; Tao K
Cancer Lett; 2017 Aug; 402():52-60. PubMed ID: 28536011
[TBL] [Abstract][Full Text] [Related]
9. Cyclin E facilitates dysplastic hepatocytes to bypass G1/S checkpoint in hepatocarcinogenesis.
Pok S; Wen V; Shackel N; Alsop A; Pyakurel P; Fahrer A; Farrell GC; Teoh NC
J Gastroenterol Hepatol; 2013 Sep; 28(9):1545-54. PubMed ID: 23574010
[TBL] [Abstract][Full Text] [Related]
10. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
[TBL] [Abstract][Full Text] [Related]
11. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
Xie YX; Liao R; Pan L; Du CY
Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
[TBL] [Abstract][Full Text] [Related]
12. Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.
Sonntag R; Giebeler N; Nevzorova YA; Bangen JM; Fahrenkamp D; Lambertz D; Haas U; Hu W; Gassler N; Cubero FJ; Müller-Newen G; Abdallah AT; Weiskirchen R; Ticconi F; Costa IG; Barbacid M; Trautwein C; Liedtke C
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9282-9287. PubMed ID: 30150405
[TBL] [Abstract][Full Text] [Related]
13. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
[TBL] [Abstract][Full Text] [Related]
14. Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways.
Chen SL; Liu LL; Wang CH; Lu SX; Yang X; He YF; Zhang CZ; Yun JP
Mol Oncol; 2020 Feb; 14(2):373-386. PubMed ID: 31670863
[TBL] [Abstract][Full Text] [Related]
15. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk.
Zhang J; Lan SJ; Liu QR; Liu JM; Chen XQ
Mol Pharmacol; 2013 May; 83(5):1109-19. PubMed ID: 23478801
[TBL] [Abstract][Full Text] [Related]
16. The Association of Peroxiredoxin 4 with the Initiation and Progression of Hepatocellular Carcinoma.
Guo X; Noguchi H; Ishii N; Homma T; Hamada T; Hiraki T; Zhang J; Matsuo K; Yokoyama S; Ishibashi H; Fukushige T; Kanekura T; Fujii J; Uramoto H; Tanimoto A; Yamada S
Antioxid Redox Signal; 2019 Apr; 30(10):1271-1284. PubMed ID: 29687726
[TBL] [Abstract][Full Text] [Related]
17. Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression.
Studach LL; Rakotomalala L; Wang WH; Hullinger RL; Cairo S; Buendia MA; Andrisani OM
Hepatology; 2009 Aug; 50(2):414-23. PubMed ID: 19472310
[TBL] [Abstract][Full Text] [Related]
18. Heat-Shock protein A12A is a novel PCNA-binding protein and promotes hepatocellular carcinoma growth.
Cheng H; Cao X; Min X; Zhang X; Kong Q; Mao Q; Li R; Xue B; Fang L; Liu L; Ding Z
FEBS J; 2020 Dec; 287(24):5464-5477. PubMed ID: 32128976
[TBL] [Abstract][Full Text] [Related]
19. Tumor-promoting/progressing role of additional chromosome instability in hepatic carcinogenesis in Sgo1 (Shugoshin 1) haploinsufficient mice.
Yamada HY; Zhang Y; Reddy A; Mohammed A; Lightfoot S; Dai W; Rao CV
Carcinogenesis; 2015 Apr; 36(4):429-40. PubMed ID: 25740822
[TBL] [Abstract][Full Text] [Related]
20. Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse model.
Srivastava J; Siddiq A; Emdad L; Santhekadur PK; Chen D; Gredler R; Shen XN; Robertson CL; Dumur CI; Hylemon PB; Mukhopadhyay ND; Bhere D; Shah K; Ahmad R; Giashuddin S; Stafflinger J; Subler MA; Windle JJ; Fisher PB; Sarkar D
Hepatology; 2012 Nov; 56(5):1782-91. PubMed ID: 22689379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
